- Home
- GOSS vs TIL Comparison
GOSS vs TIL Comparison
Compare GOSS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- TIL
- Stock Information
- Founded
- GOSS 2015
- TIL 2018
- Country
- GOSS United States
- TIL United States
- Employees
- GOSS N/A
- TIL N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- GOSS Health Care
- TIL Health Care
- Exchange
- GOSS Nasdaq
- TIL Nasdaq
- Market Cap
- GOSS 203.3M
- TIL 171.7M
- IPO Year
- GOSS 2019
- TIL 2021
- Fundamental
- Price
- GOSS $1.16
- TIL $33.49
- Analyst Decision
- GOSS Strong Buy
- TIL Buy
- Analyst Count
- GOSS 4
- TIL 5
- Target Price
- GOSS $7.75
- TIL $119.00
- AVG Volume (30 Days)
- GOSS 1.6M
- TIL 316.4K
- Earning Date
- GOSS 05-15-2025
- TIL 05-13-2025
- Dividend Yield
- GOSS N/A
- TIL N/A
- EPS Growth
- GOSS N/A
- TIL N/A
- EPS
- GOSS N/A
- TIL N/A
- Revenue
- GOSS $124,590,000.00
- TIL N/A
- Revenue This Year
- GOSS N/A
- TIL N/A
- Revenue Next Year
- GOSS $190.37
- TIL N/A
- P/E Ratio
- GOSS N/A
- TIL N/A
- Revenue Growth
- GOSS N/A
- TIL N/A
- 52 Week Low
- GOSS $0.50
- TIL $9.62
- 52 Week High
- GOSS $1.55
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- GOSS 55.35
- TIL 65.08
- Support Level
- GOSS $1.09
- TIL $12.60
- Resistance Level
- GOSS $1.20
- TIL $35.28
- Average True Range (ATR)
- GOSS 0.09
- TIL 3.84
- MACD
- GOSS 0.00
- TIL 1.60
- Stochastic Oscillator
- GOSS 69.01
- TIL 63.27
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.